Browsing Category
TPGS
PLGA-based nanoparticles for the treatment of cancer: current strategies and perspectives
Research on cancer treatment is always of great importance because of the extensive and difficult treatment options and side effects of chemotherapeutic agents. Due to this, novel techniques for cancer treatment are the need of the day. Nowadays, nanotechnology is of great interest for its…
Read More...
Read More...
Orally Dispersible Dosage Forms for Paediatric Use: Current Knowledge and Development of…
The paediatric population has always suffered from a lack of medicines tailored to their needs, especially in terms of accurate dosage, stability and acceptability. Orodispersible dosage forms have gone through a resurrection as an alternative to liquid formulations or fractioned solid formulations,…
Read More...
Read More...
Development and Characterization of Celecoxib Solid Self-nanoemulsifying Drug Delivery Systems…
Self-nanoemulsifying drug delivery systems (SNEDDS) represent an interesting platform for improving the oral bioavailability of poorly soluble lipophilic drugs. While Liquid-SNEDDS (L-SNEDDS) effectively solubilize the drug in vivo, they have several drawbacks, including poor storage stability.…
Read More...
Read More...
PEGylated SLN as a Promising Approach for Lymphatic Delivery of Gefitinib to Lung Cancer
Purpose: The present study aimed to develop gefitinib-loaded solid lipid nanoparticles (GEF-SLN), and GEF-loaded PEGylated SLN (GEF-P-SLN) for targeting metastatic lung cancer through the lymphatic system.
Methods: The prepared SLNs were characterized in terms of physicochemical properties,…
Read More...
Read More...
Solid dipersions included in poloxamer hydrogels have favorable rheological properties for topical…
Ursolic acid (UA) solid dispersions (SD) formulated into poloxamer-hydrogels were prepared for local treatment of skin inflammations. The hydrogel physico-chemical properties were evaluated, including rheology, in vitro drug permeation and cytotoxicity. The anti-inflammatory activity of the systems…
Read More...
Read More...
Pharmaceutical Applications of Vitamin E TPGS
D-tocopheryl polyethylene glycol succinate (Vitamin E TPGS) has been approved as a safe pharmaceutical adjuvant by FDA, and several drug delivery systems (DDS) based on TPGS have been developed. TPGS properties as a P-gp inhibitor, solubilizer/absorption and permeation enhancer in drug delivery and…
Read More...
Read More...
Ionic Liquids Assisted Topical Drug Delivery for Permeation Enhancement: Formulation Strategies,…
Topical drug delivery provides several benefits over other conventional routes by providing localizing therapeutic effects and also avoids the gastrointestinal tract circumventing the first-pass metabolism and enzymatic drug degradation. Being painless, the topical route also prevents the…
Read More...
Read More...
A multiscale approach to targeted docetaxel formulations: combination therapy, nanotechnology,…
Background
Cancer remains one of the leading causes of death worldwide. Docetaxel, first marketed as ‘Taxotere’, has been approved for use as a chemotherapeutic for management of gastric, breast, neck, head, non-small cell lung cancer and prostate cancer.
Main
Taxotere, is a docetaxel formulation…
Read More...
Read More...
Stimuli-responsive vitamin E-based micelles: Effective drug carriers with a controlled anticancer…
Herein, a series of vitamin E-based TPGS-poly(2-(dimethylamino)ethyl methacrylate)-b-poly(3-vinyl benzaldehyde) block copolymer micelles were synthesized via reversible addition−fragmentation chain-transfer polymerization (RAFT). d-α-tocopheryl poly(ethylene glycol) 1000 succinate (TPGS) is a good…
Read More...
Read More...
Strategies and Mechanism in Reversing Intestinal Drug Efflux in Oral Drug Delivery
Efflux transporters distributed at the apical side of human intestinal epithelial cells actively transport drugs from the enterocytes to the intestinal lumen, which could lead to extremely poor absorption of drugs by oral administration. Typical intestinal efflux transporters involved in oral drug…
Read More...
Read More...